{
"info": {
"nct_id": "NCT00975182",
"official_title": "A Phase Ib, Open-Label, Dose-Escalation Study of the Safety and Pharmacology of GDC-0941 in Combination With Erlotinib in Patients With Advanced Solid Tumors",
"inclusion_criteria": "* Documented locally advanced or metastatic solid tumors for which standard therapy either does not exist or has proven ineffective or intolerable (dose-escalation stage only)\n* Documented locally advanced or metastatic NSCLC in patients who have failed at least one prior chemotherapy-based regimen for incurable disease (cohort-expansion stage only)\n* Adequate organ function as assessed by laboratory tests\n* Evaluable disease or disease measurable per Response Evaluation Criteria in Solid Tumors (RECIST)\n* Agreement to use an effective form of contraception for the duration of the study\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Any anti-cancer therapy (e.g., chemotherapy, biologic therapy, or hormonal therapy) within a specified timeframe prior to first study treatment\n* Prior treatment with PI3K pathway-inhibiting agents (cohort-expansion stage only)\n* History of Grade >= 3 fasting hyperglycemia or diabetes requiring regular medication\n* Current clinically significant and uncontrolled systemic disease (e.g., cardiovascular, pulmonary, or metabolic)\n* History of clinically significant cardiac or pulmonary dysfunction\n* History of malabsorption syndrome or other condition that would interfere with enteral absorption\n* Clinically significant history of liver disease\n* Any condition requiring full-dose anticoagulants, such as warfarin, heparin, or thrombolytic agents\n* Active autoimmune disease and/or need for corticosteroid therapy\n* Known brain metastases that are untreated, symptomatic, or require therapy\n* Pregnancy, lactation, or breastfeeding",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Documented locally advanced or metastatic solid tumors for which standard therapy either does not exist or has proven ineffective or intolerable (dose-escalation stage only)",
"criterions": [
{
"exact_snippets": "Documented locally advanced or metastatic solid tumors",
"criterion": "solid tumors",
"requirements": [
{
"requirement_type": "stage",
"expected_value": [
"locally advanced",
"metastatic"
]
}
]
},
{
"exact_snippets": "standard therapy either does not exist or has proven ineffective or intolerable",
"criterion": "standard therapy",
"requirements": [
{
"requirement_type": "existence",
"expected_value": false
},
{
"requirement_type": "effectiveness",
"expected_value": false
},
{
"requirement_type": "tolerability",
"expected_value": false
}
]
}
]
},
{
"line": "* Documented locally advanced or metastatic NSCLC in patients who have failed at least one prior chemotherapy-based regimen for incurable disease (cohort-expansion stage only)",
"criterions": [
{
"exact_snippets": "Documented locally advanced or metastatic NSCLC",
"criterion": "NSCLC",
"requirements": [
{
"requirement_type": "stage",
"expected_value": [
"locally advanced",
"metastatic"
]
}
]
},
{
"exact_snippets": "patients who have failed at least one prior chemotherapy-based regimen for incurable disease",
"criterion": "prior chemotherapy-based regimen",
"requirements": [
{
"requirement_type": "outcome",
"expected_value": "failed"
},
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1,
"unit": "regimen"
}
}
]
}
]
},
{
"line": "* Adequate organ function as assessed by laboratory tests",
"criterions": [
{
"exact_snippets": "Adequate organ function",
"criterion": "organ function",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": true
}
]
},
{
"exact_snippets": "assessed by laboratory tests",
"criterion": "laboratory tests",
"requirements": [
{
"requirement_type": "assessment method",
"expected_value": "laboratory tests"
}
]
}
]
},
{
"line": "* Evaluable disease or disease measurable per Response Evaluation Criteria in Solid Tumors (RECIST)",
"criterions": [
{
"exact_snippets": "Evaluable disease",
"criterion": "disease",
"requirements": [
{
"requirement_type": "evaluability",
"expected_value": true
}
]
},
{
"exact_snippets": "disease measurable per Response Evaluation Criteria in Solid Tumors (RECIST)",
"criterion": "disease",
"requirements": [
{
"requirement_type": "measurability",
"expected_value": "per Response Evaluation Criteria in Solid Tumors (RECIST)"
}
]
}
]
},
{
"line": "* Agreement to use an effective form of contraception for the duration of the study",
"criterions": [
{
"exact_snippets": "Agreement to use an effective form of contraception",
"criterion": "contraception use",
"requirements": [
{
"requirement_type": "agreement",
"expected_value": true
},
{
"requirement_type": "duration",
"expected_value": "for the duration of the study"
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Any anti-cancer therapy (e.g., chemotherapy, biologic therapy, or hormonal therapy) within a specified timeframe prior to first study treatment",
"criterions": [
{
"exact_snippets": "Any anti-cancer therapy (e.g., chemotherapy, biologic therapy, or hormonal therapy) within a specified timeframe prior to first study treatment",
"criterion": "anti-cancer therapy",
"requirements": [
{
"requirement_type": "timeframe",
"expected_value": "within a specified timeframe prior to first study treatment"
}
]
}
]
},
{
"line": "* Prior treatment with PI3K pathway-inhibiting agents (cohort-expansion stage only)",
"criterions": [
{
"exact_snippets": "Prior treatment with PI3K pathway-inhibiting agents",
"criterion": "prior treatment with PI3K pathway-inhibiting agents",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* History of Grade >= 3 fasting hyperglycemia or diabetes requiring regular medication",
"criterions": [
{
"exact_snippets": "History of Grade >= 3 fasting hyperglycemia",
"criterion": "fasting hyperglycemia",
"requirements": [
{
"requirement_type": "grade",
"expected_value": {
"operator": ">=",
"value": 3,
"unit": "N/A"
}
},
{
"requirement_type": "history",
"expected_value": true
}
]
},
{
"exact_snippets": "diabetes requiring regular medication",
"criterion": "diabetes",
"requirements": [
{
"requirement_type": "medication requirement",
"expected_value": true
}
]
}
]
},
{
"line": "* Current clinically significant and uncontrolled systemic disease (e.g., cardiovascular, pulmonary, or metabolic)",
"criterions": [
{
"exact_snippets": "clinically significant and uncontrolled systemic disease",
"criterion": "systemic disease",
"requirements": [
{
"requirement_type": "significance",
"expected_value": "clinically significant"
},
{
"requirement_type": "control",
"expected_value": false
}
]
},
{
"exact_snippets": "cardiovascular",
"criterion": "cardiovascular disease",
"requirements": [
{
"requirement_type": "control",
"expected_value": false
}
]
},
{
"exact_snippets": "pulmonary",
"criterion": "pulmonary disease",
"requirements": [
{
"requirement_type": "control",
"expected_value": false
}
]
},
{
"exact_snippets": "metabolic",
"criterion": "metabolic disease",
"requirements": [
{
"requirement_type": "control",
"expected_value": false
}
]
}
]
},
{
"line": "* History of clinically significant cardiac or pulmonary dysfunction",
"criterions": [
{
"exact_snippets": "History of clinically significant cardiac ... dysfunction",
"criterion": "cardiac dysfunction",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
},
{
"requirement_type": "severity",
"expected_value": "clinically significant"
}
]
},
{
"exact_snippets": "History of clinically significant ... pulmonary dysfunction",
"criterion": "pulmonary dysfunction",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
},
{
"requirement_type": "severity",
"expected_value": "clinically significant"
}
]
}
]
},
{
"line": "* History of malabsorption syndrome or other condition that would interfere with enteral absorption",
"criterions": [
{
"exact_snippets": "History of malabsorption syndrome",
"criterion": "malabsorption syndrome",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
},
{
"exact_snippets": "other condition that would interfere with enteral absorption",
"criterion": "condition interfering with enteral absorption",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Clinically significant history of liver disease",
"criterions": [
{
"exact_snippets": "Clinically significant history of liver disease",
"criterion": "liver disease",
"requirements": [
{
"requirement_type": "history",
"expected_value": "clinically significant"
}
]
}
]
},
{
"line": "* Any condition requiring full-dose anticoagulants, such as warfarin, heparin, or thrombolytic agents",
"criterions": [
{
"exact_snippets": "Any condition requiring full-dose anticoagulants",
"criterion": "condition requiring full-dose anticoagulants",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "such as warfarin, heparin, or thrombolytic agents",
"criterion": "use of anticoagulants",
"requirements": [
{
"requirement_type": "specific drugs",
"expected_value": [
"warfarin",
"heparin",
"thrombolytic agents"
]
}
]
}
]
},
{
"line": "* Active autoimmune disease and/or need for corticosteroid therapy",
"criterions": [
{
"exact_snippets": "Active autoimmune disease",
"criterion": "autoimmune disease",
"requirements": [
{
"requirement_type": "activity",
"expected_value": true
}
]
},
{
"exact_snippets": "need for corticosteroid therapy",
"criterion": "corticosteroid therapy",
"requirements": [
{
"requirement_type": "necessity",
"expected_value": true
}
]
}
]
},
{
"line": "* Known brain metastases that are untreated, symptomatic, or require therapy",
"criterions": [
{
"exact_snippets": "Known brain metastases",
"criterion": "brain metastases",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "untreated",
"criterion": "brain metastases treatment status",
"requirements": [
{
"requirement_type": "treatment status",
"expected_value": "untreated"
}
]
},
{
"exact_snippets": "symptomatic",
"criterion": "brain metastases symptoms",
"requirements": [
{
"requirement_type": "symptoms",
"expected_value": true
}
]
},
{
"exact_snippets": "require therapy",
"criterion": "brain metastases therapy requirement",
"requirements": [
{
"requirement_type": "therapy requirement",
"expected_value": true
}
]
}
]
},
{
"line": "* Pregnancy, lactation, or breastfeeding",
"criterions": [
{
"exact_snippets": "Pregnancy",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "lactation",
"criterion": "lactation",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "breastfeeding",
"criterion": "breastfeeding",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}